Atlas Trials

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Clinical trial NCT06331845 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06331845
Sponsor
Fujian Cancer Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Nasopharyngeal CarcinomaIntermittent Systematic Chemotherapy
Start date
2024-05-01
Primary completion
2026-05-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.